Skip to main content
. Author manuscript; available in PMC: 2012 Sep 10.
Published in final edited form as: Adv Drug Deliv Rev. 2011 Jun 28;63(10-11):886–889. doi: 10.1016/j.addr.2011.05.015

Fig. 2.

Fig. 2

Time-sequential images of the same area of abdominal wall lymphatics (A-F) clearly show RFP-expressing XPA-1 cancer cells travel through the fluorescently labeled lymphatic vessel. These cells could be seen accumulating in the axillary lymph node (G). Again, the lymphatic system was highlighted by administration of AlexaFluor-conjugated anti-LYVE-1 antibody.

From ref. 15.